INS and lactic acidosis: We believe that in hepatic phenotype of DLD deficiency the treatment cornerstone should be prevention/early treatment of metabolic decompensation by avoiding catabolism with sufficient early intravenous glucose intake, if necessary with insulin to avoid lactic acidosis.